Toggle light / dark theme

Uremic Metabolites: Kidney Function Biomarkers

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.

At-Home Blood Testing (SiPhox Health): https://getquantify.io/mlustgarten.

Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye

SINGAPORE, 14 April 2023 – A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting these into experimental models of damaged retinas has resulted in significant vision recovery. This finding, by scientists at Duke-NUS Medical School, the Singapore Eye Research Institute and the Karolinska Institute in Sweden, marks a first step towards potentially restoring vision in eye diseases characterised by photoreceptor loss.


Research reveals a promising stem cell approach to correct photoreceptor cell degeneration, which underlies several forms of visual decline and blindness.

A more complete imaging technique could personalize cancer treatment

People don’t go into Michael Angelo’s field to be cool.

“Pathology is like the chess club of medicine,” said Angelo MD, PhD, an assistant professor of pathology at the Stanford School of Medicine. You don’t join for status — you join because you love it, he said.

Still, Angelo got the idea for a pretty cool technology when he was a young pathology resident studying the origins and trajectory of disease.

Researchers discover how stem cells choose their identity

AMOLF researchers discovered that stem cells first specialize into a functional cell and then move to their proper location—rather than the other way around.

Researchers at AMOLF, Amsterdam, and the Hubrecht institute, Utrecht, revealed a new model to show how specialize into functional cells. They found that their position in the organ is not as important as current models claim. Rather, stem cells choose their identity first and only then move to their appropriate position.

These discoveries were made using and the new TypeTracker technique, which can now be used to understand other organs at the cellular level and the effects of mutations and medications. The findings were published on August 18 in the journal Science Advances.

Researchers reverse hearing loss in mice

The research, published in Proceedings of the National Academy of Sciences, used a genetic approach to fix deafness in mice with a defective Spns2 gene, restoring their hearing abilities in low and middle frequency ranges. Researchers say this proof-of-concept study suggests that hearing impairment resulting from reduced gene activity may be reversible.

Over half of adults in their 70s experience significant hearing loss. Impaired hearing is associated with an increased likelihood of experiencing depression and cognitive decline, as well as being a major predictor of dementia. While hearing aids and cochlear implants may be useful, they do not restore normal hearing function, and neither do they halt disease progression in the ear. There is a significant unmet need for medical approaches that slow down or reverse hearing loss.


New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has successfully reversed hearing loss in mice.

This proof-of-concept study suggests that gene therapy for this type of hearing loss in humans may be successful in the future.

How Long Should You Live? Star Trek, Dr. Emanuel, & The Ethics of Life Extension

I will try to live as long as possible.


Dr. Ezekiel Emanuel plans to reject life-extending medical care at the age of 75. The reason he does this is quite similar to why the Kaelons commit ritual suicide in Star Trek: The Next Generation. Does this make sense?

In this thought-provoking episode of Lifespan News, host Ryan O’Shea delves deep into the controversial topic of choosing when to die and the ethics surrounding medical interventions to prolong life. Using the lens of a Star Trek: The Next Generation episode and drawing parallels with Dr. Ezekiel Emanuel’s The Atlantic article, “Why I Hope to Die at 75″, Ryan confronts the moral and societal implications of setting an arbitrary age to stop seeking medical treatment. With advancements in rejuvenation biotechnologies, is it reasonable to maintain such views? As we push the boundaries of science and healthcare, when should we draw the line? Join Ryan as he navigates these complex questions, and remember to share your thoughts in the comments below. Don’t forget to subscribe for more!

Video Clips:
Leading US doctor says he won’t get treatment if he gets cancer after 75, CNN — https://www.youtube.com/watch?v=TgrO4rrrFgQ

How Long Do You Want to Live?, The Atlantic — https://youtu.be/fQBzY-aorFQ

/* */